Supporting the

Neuroendocrine Cancer Community

The Impact of COVID-19 on the Management of NETS

Oct 17, 2022

INCA Supported a Study on the Impact of COVID-19 on NET Management, Now Published in the Journal of Neuroendocrinology

An abstract of a study with the active involvement of the global neuroendocrine tumor (NET) community was published in the Journal of Neuroendocrinology. The study is titled “The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients”. INCA member organizations supported the survey by distributing it among patients across the globe.

Catherine Bouvier Ellis, Immediate Past President of INCA and CEO of Neuroendocrine Cancer UK, is part of the team of authors including: Mauro Cives, Jorge Hernando, Angela Lamarca, Martyn Caplin, Marianne Pavel.

The COVID-19 outbreak has added complexity to the management of patients with neuroendocrine tumors (NETs). Little information is currently available regarding the real impact of the pandemic in current practice. The study aimed to capture patients’ and healthcare professionals’ experiences on how NET management has changed during the pandemic and how it should be modified in a foreseeable post-pandemic environment. Deferred diagnoses, delayed surveillance procedures and postponed elective surgeries were among the main negative consequences of the COVID-19 outbreak according to 40%, 54% and 46% of healthcare professionals (HPs) respectively.

Read article here

 

Infographic produced by NET CONNECT and COR2ED